ClinicalTrials.Veeva

Menu

Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.

A

Assiut University

Status

Unknown

Conditions

Chronic Kidney Diseases

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Secondary hyperparathyroidism is an important complication in patient with chronic kidney disease . It is associated with bone complication and an increase in cardiovascular mortality The parathyroid hormone rises in these patients as consequence of low concentration of vitamin D3 ,reduction in quantities of serum calcium, phosphorus retention and reduction of vitamin D receptors sensitive to calcium.

Enrollment

30 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stage 5 chronic renal failure
  • dialysis (peritoneal ,or hemodialysis) since 3---5 years

Exclusion criteria

  • previous of neck surgery.
  • Patients refusal to participate in the study or voluntary withdrawal

Trial design

30 participants in 1 patient group

chronic kidney diseases
Description:
patients with chronic renal failure on dialysis since 3-5 years

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Abbas; Ahmed Abbas

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems